IDO1 and lung carcinoma: Moreover, IDO1 induces NK cell dysfunction via downregulation of the activating receptor NKG2D on NK cells by inhibiting NKG2D ligand (NGD2DL) expression on lung cancer cells via the IDO1-Kyn-AhR signaling pathway [93].